AU2001248772A1 - Sustained release drug compositions - Google Patents

Sustained release drug compositions

Info

Publication number
AU2001248772A1
AU2001248772A1 AU2001248772A AU4877201A AU2001248772A1 AU 2001248772 A1 AU2001248772 A1 AU 2001248772A1 AU 2001248772 A AU2001248772 A AU 2001248772A AU 4877201 A AU4877201 A AU 4877201A AU 2001248772 A1 AU2001248772 A1 AU 2001248772A1
Authority
AU
Australia
Prior art keywords
sustained release
release drug
drug compositions
compositions
sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001248772A
Inventor
Rie Igarashi
Aki Kitagawa
Yutaka Mizushima
Yukie Takagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTT Institute Co Ltd
Original Assignee
LTT Institute Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTT Institute Co Ltd filed Critical LTT Institute Co Ltd
Publication of AU2001248772A1 publication Critical patent/AU2001248772A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
AU2001248772A 2000-04-17 2001-04-17 Sustained release drug compositions Abandoned AU2001248772A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000115091 2000-04-17
JP2000-115091 2000-04-17
JP2000-203850 2000-07-05
JP2000203850A JP2002003398A (en) 2000-04-17 2000-07-05 Sustained-release preparation, method for preparing the same, and vaccine therefrom
PCT/JP2001/003287 WO2001078682A2 (en) 2000-04-17 2001-04-17 Sustained release drug compositions

Publications (1)

Publication Number Publication Date
AU2001248772A1 true AU2001248772A1 (en) 2001-10-30

Family

ID=26590219

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001248772A Abandoned AU2001248772A1 (en) 2000-04-17 2001-04-17 Sustained release drug compositions

Country Status (5)

Country Link
US (1) US20020019336A1 (en)
EP (1) EP1276506A2 (en)
JP (1) JP2002003398A (en)
AU (1) AU2001248772A1 (en)
WO (1) WO2001078682A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050043234A1 (en) 1996-10-16 2005-02-24 Deisher Theresa A. Novel FGF homologs
JP2003081865A (en) * 2001-09-12 2003-03-19 Ltt Institute Co Ltd Water-insoluble sustained-release composition, its preparation and method for producing the same
DE10209821A1 (en) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Coupling of proteins to a modified polysaccharide
BR0314107A (en) 2002-09-11 2005-07-19 Fresenius Kabi De Gmbh Production method of hydroxyalkyl starch derivatives
EP1551426B1 (en) * 2002-10-07 2014-06-25 ZymoGenetics, Inc. Methods of administering fgf18
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
WO2005092928A1 (en) 2004-03-11 2005-10-06 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
GB0502661D0 (en) * 2005-02-09 2005-03-16 Stabilitech Ltd A desiccated product
WO2008008007A1 (en) 2006-07-13 2008-01-17 St. Jude Medical Ab An implantable cardiac stimulation drug releasing electrode
EP2070950A1 (en) 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Hydroxyalkyl starch derivatives and process for their preparation
EP2111871A1 (en) * 2008-04-26 2009-10-28 Sandoz AG Stabilised fluid formula
EP3079668A1 (en) 2013-12-09 2016-10-19 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
US10953103B2 (en) 2015-11-06 2021-03-23 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V Composition comprising a biocompatible and biodegradable polymer, nanocarriers and a drug and methods of making and using the same
EP3986378A1 (en) 2019-06-21 2022-04-27 Alfasigma S.p.A. Pharmaceutical compositions in the form of gel containing xyloglucan and alcohols for the controlled release of active ingredients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
ES2054815T3 (en) * 1987-09-08 1994-08-16 Takeda Chemical Industries Ltd INSOLUBILIZED CYTOKINES IN WATER.
WO1992013547A1 (en) * 1991-02-07 1992-08-20 Alexander Mellon Eaton Drug delivery composition and method of using the same
EP0503583A1 (en) * 1991-03-12 1992-09-16 Takeda Chemical Industries, Ltd. Composition for sustained release of erythropoietin
ATE173405T1 (en) * 1991-07-10 1998-12-15 Takeda Chemical Industries Ltd MEDICINAL PRODUCTS BASED ON HYALURONIC ACID
US5344644A (en) * 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release
KR20010003853A (en) * 1999-06-25 2001-01-15 박호군 Vaccine compositions using antigens encapsulated within alginate microspheres for oral administration and preparation process thereof

Also Published As

Publication number Publication date
WO2001078682A2 (en) 2001-10-25
US20020019336A1 (en) 2002-02-14
WO2001078682A3 (en) 2002-04-18
EP1276506A2 (en) 2003-01-22
JP2002003398A (en) 2002-01-09

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
AU2002258563A1 (en) Pharmaceutical formulations for sustained release
AU2001250420A1 (en) Pharmaceutical compositions
AU2002229140A1 (en) Controlled release pharmaceutical composition
AU2001274307A1 (en) Pharmaceutical compositions
AU2002337803A1 (en) Sustained release pharmaceutical compositions
AU2003262059A1 (en) Sustained release preparation
IL159048A0 (en) Sustained release formulation
HUP0204409A3 (en) Sustained release ranolazine pharmaceutical compositions
AU2002313236A1 (en) Medicinal compositions
AUPR602501A0 (en) Sustained release pharmaceutical composition
AU2001264264A1 (en) Sustained release compositions
AU2003260803A1 (en) Sustained release pharmaceutical composition
AU2002214324A1 (en) Medicinal compositions
HUP0301177A3 (en) Ion-strength independent sustained release pharmaceutical formulation
AU2001290239A1 (en) Medicinal composition
AU2001248772A1 (en) Sustained release drug compositions
AU2002221115A1 (en) Medicinal compositions having improved absorbability
AU2001246861A1 (en) Sustained release preparations
AU2001273919A1 (en) Pharmaceutical compositions
AU2002221099A1 (en) Combination drugs
AU2001232244A1 (en) Drug comprising combination
AU2002226047A1 (en) Release agent composition
AU4085201A (en) Pharmaceutical composition
AU2001259252A1 (en) Neuroprotective compositions